Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Aspects Med. 2011 Aug;32(4-6):258-66. doi: 10.1016/j.mam.2011.10.009. Epub 2011 Oct 15.

Neuroprotective features of carnosine in oxidative driven diseases.

Author information

1
University of Catania, Department of Chemical Sciences, Viale A. Doria 6, 95125 Catania, Italy.

Abstract

Carnosine (β-alanyl-L-histidine) is a natural dipeptide widely and abundantly distributed in excitable tissues of several animal tissues. Although its physiological role has not been completely understood yet, many beneficial actions have been attributed to carnosine, such as being an antioxidant, antiglycating and ion-chelating agent, a wound healing promoter and a free-radical scavenger. The role of carnosine in the neuroprotection of oxidative stress-driven disorders has been reviewed. The effects of carnosine have been extensively studied both in vivo and in vitro models of cerebral damages, such as neurodegenerative disorders and hypoxia-ischemia injuries. Beside the classical sacrificial agent, carnosine has been reevaluated as a molecular chaperon and an inducer of antioxidant systems in oxidative stress conditions. Thus, beneficial effects on most of the common biochemical events that characterize neurological disorders make carnosine a very promising molecule among all the endogenous compounds in the treatment and/or prevention of oxidative driven diseases.

PMID:
22020110
DOI:
10.1016/j.mam.2011.10.009
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center